www.cutaquiginfo.com
Open in
urlscan Pro
2606:4700:4400::6812:2628
Public Scan
Submitted URL: https://www.cutaquigcopay.com/
Effective URL: https://www.cutaquiginfo.com/support-and-resources.html
Submission: On November 03 via api from US — Scanned from US
Effective URL: https://www.cutaquiginfo.com/support-and-resources.html
Submission: On November 03 via api from US — Scanned from US
Form analysis
1 forms found in the DOM./search.html
<form class="search" action="./search.html">
<div class="search__textbox">
<input type="text" id="tipue_search_input" class="search__text form-control" placeholder="search" onfocus="this.placeholder=''" onblur="this.placeholder='SEARCH'" name="q" pattern=".{3,}" title="At least 3 characters" autocomplete="off"
required="">
</div>
<div class="search__btnWrapper">
<button id="tipue_search_button" type="submit" class="search__btn tipue_search_button">Submit</button>
</div>
</form>
Text Content
SORRY, YOUR BROWSER DOES NOT SUPPORT JAVASCRIPT! Skip to main content Indication Important Safety Information Patient Information Full Prescribing Information & BOXED WARNING For Healthcare Professionals WHAT IS CUTAQUIG? CUTAQUIG (Immune Globulin Subcutaneous [Human] - hipp) is a 16.5% immune globulin solution for subcutaneous infusion indicated for treatment of primary humoral immunodeficiency (PI) in adults and pediatric patients 2 years of age and older. There are many forms of PI. Certain types of PI are associated with low immunoglobulin G (IgG), which are proteins that help fight infection. CUTAQUIG is a liquid medicine for infusion that contains immunoglobulin G (IgG), which are proteins that help fight infection. It is made from human plasma that is donated by healthy people and contains antibodies that replace the missing antibodies in patients with PI. CUTAQUIG is given under the skin (subcutaneous). Most of the time, infusions under the skin are given at home by self-infusion or by a caregiver. Only use CUTAQUIG by yourself after you have been instructed on use by a healthcare provider (HCP). x * About cutaquig * Cutaquig infusions * How do I administer cutaquig? * What to expect when starting treatment * Infusing and storing cutaquig * Support and resources * Resources * FAQs * SIGN UP FOR MyCutaquig Submit Menu YOU ARE LEAVING CUTAQUIGINFO.COM You are leaving cutaquiginfo.com. The information provided in this website is intended only for healthcare professionals in the United States. The products discussed herein may have different product labeling in different countries. Continue Stay on this site YOU ARE LEAVING CUTAQUIGINFO.COM Links to all outside websites are provided as a convenience to our visitors and do not imply an endorsement or recommendation by Pfizer. Pfizer accepts no responsibility or liability for the content or services of other websites. Continue Stay on this site Financial assistance PI patient testimonial Tools and resources FOR ELIGIBLE PATIENTS PRESCRIBED CUTAQUIG, PFIZER'S CUTAQUIG CO-PAY PROGRAM MAY OFFER SAVINGS X Play Video Play Mute Current Time 0:00 / Duration Time 0:00 Loaded: 0% Progress: 0% Stream TypeLIVE Remaining Time -0:00 Playback Rate 1 * Chapters Chapters * descriptions off, selected Descriptions * subtitles off, selected Subtitles * captions settings, opens captions settings dialog * captions off, selected Captions Audio Track Fullscreen This is a modal window. Caption Settings Dialog Beginning of dialog window. Escape will cancel and close the window. TextColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentBackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparentWindowColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaque Font Size50%75%100%125%150%175%200%300%400% Text Edge StyleNoneRaisedDepressedUniformDropshadow Font FamilyProportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall Caps DefaultsDone Close Modal Dialog This is a modal window. This modal can be closed by pressing the Escape key or activating the close button. ELIGIBLE, COMMERCIALLY INSURED PATIENTS MAY REDUCE OUT-OF-POCKET COSTS BY UP TO $12,500 PER CALENDAR YEAR (RENEWED EVERY JANUARY)* OR THE COST OF PATIENT’S CO-PAY IN A 12-MONTH PERIOD, WHICHEVER IS LESS *Terms and conditions apply. See full terms and conditions below. Patients must be 2 years or older to be eligible. Patients must have commercial insurance to be eligible. Patients are not eligible if they are enrolled in a state or federally funded insurance program. SPECIALTY INFUSION PHARMACIES MAY ENROLL ELIGIBLE PATIENTS. TERMS AND CONDITIONS By using this co-pay card, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below: * Patients are not eligible to use this card if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as “La Reforma de Salud”). * Patient must have private insurance. Offer is not valid for cash paying patients. The value of this co-pay card is limited to a maximum of $12,500 per calendar year or the cost of patient co-pay in a 12-month period, whichever is less. * This co-pay card is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plan or other private health or pharmacy benefit programs. * You must deduct the value of this co-pay card from any reimbursement request submitted to your private insurance plan, either directly by you or on your behalf. * You are responsible for reporting use of the co-pay card to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the co-pay card, as may be required. You should not use the co-pay card if your insurer or health plan prohibits use of manufacturer co-pay cards. * The patient must be 2 years of age or older for redemption of co-pay card. * This co-pay card is not valid where prohibited by law. * Co-pay card cannot be combined with any other savings, free trial or similar offer for the specified prescription. * Co-pay card will be accepted only at participating pharmacies. * If your pharmacy does not participate, you may be able to submit a request for a rebate in connection with this offer. * This co-pay card is not health insurance. * Offer good only in the U.S. and Puerto Rico. * Co-pay card is limited to 1 per person during this offering period and is not transferable. * A co-pay card may not be redeemed more than once per 5 days per patient. * Co-pay card is limited to reimbursement of Pfizer-labeled CUTAQUIG® (Immune Globulin Subcutaneous [Human] - hipp) only. * No other purchase is necessary. * No membership fee. * Data related to your redemption of the co-pay card may be collected, analyzed, and shared with Pfizer for market research and other purposes related to assessing Pfizer’s programs. Data shared with Pfizer will be aggregated and de-identified; it will be combined with data related to other co-pay card redemptions and will not identify you. * Pfizer reserves the right to rescind, revoke or amend this offer without notice. * Offer expires 12/31/2023. For more information, call 1-866-293-5922, or write: CUTAQUIG Co-Pay Program P.O. Box 6875 Bridgewater, NJ 08807 WHAT IS PFIZER IGUIDETM? Pfizer IGuideTM can help you understand your insurance coverage and out-of-pocket costs for your cutaquig prescription, as well as identify financial assistance options for which you may be eligible. If you have been prescribed cutaquig and have questions about your coverage, call Pfizer IGuide™ Monday through Friday, 8 AM to 8 PM ET, at 1-844-448-4337. Financial Assistance * Pfizer IGuideTM can help identify financial assistance resources for which you may be eligible to help with out-of-pocket costs for cutaquig Commercially Insured Patients * If you have commercial, employer, or private coverage, including coverage purchased through a state health insurance marketplace, you may be eligible for the cutaquig co-pay program, which can help cover the cost of your co-pay. Eligible patients may pay as little as $0 per cutaquig treatment. The value of the co-pay card is limited to a maximum of $12,500 per calendar year. See terms and conditions above Medicare/Government-Insured Patients * If you have government-funded insurance and need help to cover the cost of cutaquig, Pfizer IGuideTM can help identify financial support options including alternate coverage resources, if available Uninsured Patients * If you do not have health insurance and cannot afford your cutaquig treatment, Pfizer IGuideTM can connect you to potential resources that may help cover the cost of cutaquig, including how to apply to Medicaid if you may be eligible HEAR A CUTAQUIG STORY Meet John, diagnosed with PI in 2018 "I haven't been hospitalized for an infection now that I'm on cutaquig." Watch John's story. RESOURCES FOR YOU THROUGHOUT YOUR TREATMENT JOURNEY Cutaquig offers a variety of downloadable resources with information about treatment, guides to keep track of your dosing, and more. PATIENT BROCHURE A brochure with information about cutaquig and tips on managing PI. Download the patient brochure Click here to download the Full Prescribing Information SPANISH PATIENT BROCHURE Helps educate Spanish-speaking patients about cutaquig. Download the Spanish patient brochure Click here to download the Full Prescribing Information CUTAQUIG SCIG THERAPY VIDEO Shows an overview of cutaquig. Watch the video Click here to download the Full Prescribing Information INFUSION GUIDE A step-by-step guide to help teach you how to self-administer cutaquig. Download the infusion guide Click here to download the Full Prescribing Information PATIENT INFUSION VIDEO Shows how to self-administer cutaquig. Watch the video Click here to download the Full Prescribing Information INFUSION JOURNAL A journal to help you keep an accurate record of each time cutaquig is administered. Download the infusion journal Click here to download the Full Prescribing Information PFIZER CUTAQUIG CO-PAY PROGRAM BROCHURE A brochure that helps eligible patients currently prescribed cutaquig get financial relief. Download the brochure Click here to download the Full Prescribing Information IG COMPANION OVERVIEW VIDEO Video highlighting the Ig Companion free mobile app for patients on Ig treatment. Watch the video Click here to download the Full Prescribing Information PI PATIENT TESTIMONIAL Hear from John about his path to SCIg therapy and how cutaquig helped him. Watch the video Click here to download the Full Prescribing Information Important Safety Information and Indications IMPORTANT SAFETY INFORMATION WARNING: THROMBOSIS See full Prescribing Information for complete BOXED WARNING * Thrombosis may occur with immune globulin products, including CUTAQUIG. Risk factors may include advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling vascular catheters, hyperviscosity, and cardiovascular risk factors. * For patients at risk of thrombosis, administer CUTAQUIG at the minimum dose and infusion rate practicable. Ensure adequate hydration in patients before administration. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk of hyperviscosity. What is the most important information I need to know about CUTAQUIG? CUTAQUIG can cause the following serious reactions: * Severe allergic reactions causing difficulty in breathing or skin rashes * Blood clots in the heart, brain, lungs, or elsewhere in the body * Severe headache, drowsiness, fever, painful eye movements, or nausea and vomiting * Decreased kidney function or kidney failure * Dark colored urine, swelling, fatigue, or difficulty breathing CUTAQUIG is made from human blood. The risk of transmission of infectious agents, including viruses, the variant Creutzfeldt-Jakob disease (vCJD) agent, and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent cannot be completely eliminated. What should I know while taking CUTAQUIG? * CUTAQUIG can make vaccines (like measles/mumps/rubella or chickenpox vaccines) not work as well for you. Before you get any vaccines, tell your HCP that you take CUTAQUIG * Tell your HCP if you are pregnant, or plan to become pregnant, or if you are nursing CUTAQUIG can cause serious side effects. If any of the following problems occur after starting CUTAQUIG, contact your HCP or call emergency services. If any of the following problems occur during CUTAQUIG infusion, stop the infusion immediately and contact your HCP or call emergency services: * Hives, swelling in the mouth or throat, itching, trouble breathing, wheezing, fainting, or dizziness. These could be signs of a serious allergic reaction * Bad headache with nausea, vomiting, stiff neck, fever, and sensitivity to light. These could be signs of irritation and swelling of the lining around your brain * Reduced urination, sudden weight gain, or swelling in your legs. These could be signs of a kidney problem * Pain, swelling, warmth, redness, or a lump in your legs or arms. These could be signs of a blood clot * Brown or red urine, fast heart rate, yellow skin or eyes. These could be signs of a liver or blood problem * Chest pain or trouble breathing, or blue lips or extremities. These could be signs of a serious heart or lung problem * Fever over 100°F. This could be a sign of an infection Ask your HCP whether you should have rescue medications available, such as antihistamines or epinephrine. What are the possible or reasonably likely side effects of CUTAQUIG? The most common side effects of CUTAQUIG are: * Infusion site reactions (including but not limited to redness, swelling, itching, fluid in tissue, pain, mass, bruising) * Headache * Elevated body temperature One or more of the following possible side effects may occur at the site of infusion; these may go away within a few hours and are less likely after the first few infusions: * Mild or moderate pain * Redness * Itching These are not all the possible side effects. Talk to your HCP about any side effect that bothers you or that does not go away. INDICATIONS AND USAGE CUTAQUIG (Immune Globulin Subcutaneous [Human] - hipp) is a 16.5% immune globulin solution for subcutaneous infusion indicated for treatment of primary humoral immunodeficiency (PI) in adults and pediatric patients 2 years of age and older. There are many forms of PI. Certain types of PI are associated with low immunoglobulin G (IgG), which are proteins that help fight infection. CUTAQUIG is a liquid medicine for infusion that contains immunoglobulin G (IgG), which are proteins that help fight infection. It is made from human plasma that is donated by healthy people and contains antibodies that replace the missing antibodies in patients with PI. CUTAQUIG is given under the skin (subcutaneous). Most of the time, infusions under the skin are given at home by self-infusion or by a caregiver. Only use CUTAQUIG by yourself after you have been instructed on use by a healthcare provider (HCP). Please click here for Full Prescribing Information, including complete BOXED WARNING and Patient Information and Instructions for Use. IMPORTANT SAFETY INFORMATION ISI ISI ISI ISI Important Safety Information and Indications WARNING: THROMBOSIS See full Prescribing Information for complete BOXED WARNING * Thrombosis may occur with immune globulin products, including CUTAQUIG. Risk factors may include advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling vascular catheters, hyperviscosity, and cardiovascular risk factors. * For patients at risk of thrombosis, administer CUTAQUIG at the minimum dose and infusion rate practicable. Ensure adequate hydration in patients before administration. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk of hyperviscosity. What is the most important information I need to know about CUTAQUIG? CUTAQUIG can cause the following serious reactions: * Severe allergic reactions causing difficulty in breathing or skin rashes * Blood clots in the heart, brain, lungs, or elsewhere in the body * Severe headache, drowsiness, fever, painful eye movements, or nausea and vomiting * Decreased kidney function or kidney failure * Dark colored urine, swelling, fatigue, or difficulty breathing CUTAQUIG is made from human blood. The risk of transmission of infectious agents, including viruses, the variant Creutzfeldt-Jakob disease (vCJD) agent, and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent cannot be completely eliminated. What should I know while taking CUTAQUIG? * CUTAQUIG can make vaccines (like measles/mumps/rubella or chickenpox vaccines) not work as well for you. Before you get any vaccines, tell your HCP that you take CUTAQUIG * Tell your HCP if you are pregnant, or plan to become pregnant, or if you are nursing CUTAQUIG can cause serious side effects. If any of the following problems occur after starting CUTAQUIG, contact your HCP or call emergency services. If any of the following problems occur during CUTAQUIG infusion, stop the infusion immediately and contact your HCP or call emergency services: * Hives, swelling in the mouth or throat, itching, trouble breathing, wheezing, fainting, or dizziness. These could be signs of a serious allergic reaction * Bad headache with nausea, vomiting, stiff neck, fever, and sensitivity to light. These could be signs of irritation and swelling of the lining around your brain * Reduced urination, sudden weight gain, or swelling in your legs. These could be signs of a kidney problem * Pain, swelling, warmth, redness, or a lump in your legs or arms. These could be signs of a blood clot * Brown or red urine, fast heart rate, yellow skin or eyes. These could be signs of a liver or blood problem * Chest pain or trouble breathing, or blue lips or extremities. These could be signs of a serious heart or lung problem * Fever over 100°F. This could be a sign of an infection Ask your HCP whether you should have rescue medications available, such as antihistamines or epinephrine. What are the possible or reasonably likely side effects of CUTAQUIG? The most common side effects of CUTAQUIG are: * Infusion site reactions (including but not limited to redness, swelling, itching, fluid in tissue, pain, mass, bruising) * Headache * Elevated body temperature One or more of the following possible side effects may occur at the site of infusion; these may go away within a few hours and are less likely after the first few infusions: * Mild or moderate pain * Redness * Itching These are not all the possible side effects. Talk to your HCP about any side effect that bothers you or that does not go away. INDICATIONS AND USAGE CUTAQUIG (Immune Globulin Subcutaneous [Human] - hipp) is a 16.5% immune globulin solution for subcutaneous infusion indicated for treatment of primary humoral immunodeficiency (PI) in adults and pediatric patients 2 years of age and older. There are many forms of PI. Certain types of PI are associated with low immunoglobulin G (IgG), which are proteins that help fight infection. CUTAQUIG is a liquid medicine for infusion that contains immunoglobulin G (IgG), which are proteins that help fight infection. It is made from human plasma that is donated by healthy people and contains antibodies that replace the missing antibodies in patients with PI. CUTAQUIG is given under the skin (subcutaneous). Most of the time, infusions under the skin are given at home by self-infusion or by a caregiver. Only use CUTAQUIG by yourself after you have been instructed on use by a healthcare provider (HCP). Please click here for Full Prescribing Information, including complete BOXED WARNING and Patient Information and Instructions for Use. Important Safety Information and Indications IMPORTANT SAFETY INFORMATION WARNING: THROMBOSIS See full Prescribing Information for complete BOXED WARNING * Thrombosis may occur with immune globulin products, including CUTAQUIG. Risk factors may include advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling vascular catheters, hyperviscosity, and cardiovascular risk factors. * For patients at risk of thrombosis, administer CUTAQUIG at the minimum dose and infusion rate practicable. Ensure adequate hydration in patients before administration. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk of hyperviscosity. What is the most important information I need to know about CUTAQUIG? CUTAQUIG can cause the following serious reactions: * Severe allergic reactions causing difficulty in breathing or skin rashes * Blood clots in the heart, brain, lungs, or elsewhere in the body * Severe headache, drowsiness, fever, painful eye movements, or nausea and vomiting * Decreased kidney function or kidney failure * Dark colored urine, swelling, fatigue, or difficulty breathing CUTAQUIG is made from human blood. The risk of transmission of infectious agents, including viruses, the variant Creutzfeldt-Jakob disease (vCJD) agent, and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent cannot be completely eliminated. What should I know while taking CUTAQUIG? * CUTAQUIG can make vaccines (like measles/mumps/rubella or chickenpox vaccines) not work as well for you. Before you get any vaccines, tell your HCP that you take CUTAQUIG * Tell your HCP if you are pregnant, or plan to become pregnant, or if you are nursing CUTAQUIG can cause serious side effects. If any of the following problems occur after starting CUTAQUIG, contact your HCP or call emergency services. If any of the following problems occur during CUTAQUIG infusion, stop the infusion immediately and contact your HCP or call emergency services: * Hives, swelling in the mouth or throat, itching, trouble breathing, wheezing, fainting, or dizziness. These could be signs of a serious allergic reaction * Bad headache with nausea, vomiting, stiff neck, fever, and sensitivity to light. These could be signs of irritation and swelling of the lining around your brain * Reduced urination, sudden weight gain, or swelling in your legs. These could be signs of a kidney problem * Pain, swelling, warmth, redness, or a lump in your legs or arms. These could be signs of a blood clot * Brown or red urine, fast heart rate, yellow skin or eyes. These could be signs of a liver or blood problem * Chest pain or trouble breathing, or blue lips or extremities. These could be signs of a serious heart or lung problem * Fever over 100°F. This could be a sign of an infection Ask your HCP whether you should have rescue medications available, such as antihistamines or epinephrine. What are the possible or reasonably likely side effects of CUTAQUIG? The most common side effects of CUTAQUIG are: * Infusion site reactions (including but not limited to redness, swelling, itching, fluid in tissue, pain, mass, bruising) * Headache * Elevated body temperature One or more of the following possible side effects may occur at the site of infusion; these may go away within a few hours and are less likely after the first few infusions: * Mild or moderate pain * Redness * Itching These are not all the possible side effects. Talk to your HCP about any side effect that bothers you or that does not go away. INDICATIONS AND USAGE CUTAQUIG (Immune Globulin Subcutaneous [Human] - hipp) is a 16.5% immune globulin solution for subcutaneous infusion indicated for treatment of primary humoral immunodeficiency (PI) in adults and pediatric patients 2 years of age and older. There are many forms of PI. Certain types of PI are associated with low immunoglobulin G (IgG), which are proteins that help fight infection. CUTAQUIG is a liquid medicine for infusion that contains immunoglobulin G (IgG), which are proteins that help fight infection. It is made from human plasma that is donated by healthy people and contains antibodies that replace the missing antibodies in patients with PI. CUTAQUIG is given under the skin (subcutaneous). Most of the time, infusions under the skin are given at home by self-infusion or by a caregiver. Only use CUTAQUIG by yourself after you have been instructed on use by a healthcare provider (HCP). Please click here for Full Prescribing Information, including complete BOXED WARNING and Patient Information and Instructions for Use. Important Safety Information and Indications IMPORTANT SAFETY INFORMATION WARNING: THROMBOSIS See full Prescribing Information for complete BOXED WARNING * Thrombosis may occur with immune globulin products, including CUTAQUIG. Risk factors may include advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling vascular catheters, hyperviscosity, and cardiovascular risk factors. * For patients at risk of thrombosis, administer CUTAQUIG at the minimum dose and infusion rate practicable. Ensure adequate hydration in patients before administration. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk of hyperviscosity. What is the most important information I need to know about CUTAQUIG? CUTAQUIG can cause the following serious reactions: * Severe allergic reactions causing difficulty in breathing or skin rashes * Blood clots in the heart, brain, lungs, or elsewhere in the body * Severe headache, drowsiness, fever, painful eye movements, or nausea and vomiting * Decreased kidney function or kidney failure * Dark colored urine, swelling, fatigue, or difficulty breathing CUTAQUIG is made from human blood. The risk of transmission of infectious agents, including viruses, the variant Creutzfeldt-Jakob disease (vCJD) agent, and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent cannot be completely eliminated. What should I know while taking CUTAQUIG? * CUTAQUIG can make vaccines (like measles/mumps/rubella or chickenpox vaccines) not work as well for you. Before you get any vaccines, tell your HCP that you take CUTAQUIG * Tell your HCP if you are pregnant, or plan to become pregnant, or if you are nursing CUTAQUIG can cause serious side effects. If any of the following problems occur after starting CUTAQUIG, contact your HCP or call emergency services. If any of the following problems occur during CUTAQUIG infusion, stop the infusion immediately and contact your HCP or call emergency services: * Hives, swelling in the mouth or throat, itching, trouble breathing, wheezing, fainting, or dizziness. These could be signs of a serious allergic reaction * Bad headache with nausea, vomiting, stiff neck, fever, and sensitivity to light. These could be signs of irritation and swelling of the lining around your brain * Reduced urination, sudden weight gain, or swelling in your legs. These could be signs of a kidney problem * Pain, swelling, warmth, redness, or a lump in your legs or arms. These could be signs of a blood clot * Brown or red urine, fast heart rate, yellow skin or eyes. These could be signs of a liver or blood problem * Chest pain or trouble breathing, or blue lips or extremities. These could be signs of a serious heart or lung problem * Fever over 100°F. This could be a sign of an infection Ask your HCP whether you should have rescue medications available, such as antihistamines or epinephrine. What are the possible or reasonably likely side effects of CUTAQUIG? The most common side effects of CUTAQUIG are: * Infusion site reactions (including but not limited to redness, swelling, itching, fluid in tissue, pain, mass, bruising) * Headache * Elevated body temperature One or more of the following possible side effects may occur at the site of infusion; these may go away within a few hours and are less likely after the first few infusions: * Mild or moderate pain * Redness * Itching These are not all the possible side effects. Talk to your HCP about any side effect that bothers you or that does not go away. INDICATIONS AND USAGE CUTAQUIG (Immune Globulin Subcutaneous [Human] - hipp) is a 16.5% immune globulin solution for subcutaneous infusion indicated for treatment of primary humoral immunodeficiency (PI) in adults and pediatric patients 2 years of age and older. There are many forms of PI. Certain types of PI are associated with low immunoglobulin G (IgG), which are proteins that help fight infection. CUTAQUIG is a liquid medicine for infusion that contains immunoglobulin G (IgG), which are proteins that help fight infection. It is made from human plasma that is donated by healthy people and contains antibodies that replace the missing antibodies in patients with PI. CUTAQUIG is given under the skin (subcutaneous). Most of the time, infusions under the skin are given at home by self-infusion or by a caregiver. Only use CUTAQUIG by yourself after you have been instructed on use by a healthcare provider (HCP). Please click here for Full Prescribing Information, including complete BOXED WARNING and Patient Information and Instructions for Use. Terms of use Privacy Policy Contact Pfizer Site Map Please click here for Full Prescribing Information, including complete BOXED WARNING and Patient Information and Instructions for Use. Patients should always ask their doctors for medical advice about adverse events. You may report an adverse event related to Pfizer products by calling 1-800-438-1985 (US only). If you prefer, you may contact the US Food and Drug Administration (FDA) directly. The FDA has established a reporting service known as MedWatch where healthcare professionals and consumers can report problems they suspect may be associated with the drugs and medical devices they prescribe, dispense, or use. Visit www.fda.gov/MedWatch.com or call 1-800-FDA-1088. This site is intended only for U.S. residents. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only and is not intended to replace discussions with a healthcare provider. Pfizer PO Box 29387 Mission, KS 66201 CUTAQUIG® is a registered trademark of Octapharma AG. Manufactured by Octapharma Pharmazeutika Produktionsges m.b.H. | Distributed by Pfizer Labs, Division of Pfizer Inc. © 2023 Pfizer Inc. All rights reserved. October 2023 PP-CQG-USA-0611 back to top